Artigo
Acesso aberto
Revisado por pares
Safety and efficacy of NAD depleting cancer drugs: results of a phase I clinical trial of CHS 828 and overview of published data
2009; Springer Science+Business Media; Volume: 65; Issue: 6 Linguagem: Inglês
10.1007/s00280-009-1125-3
ISSN1432-0843
AutoresAnne von Heideman, Åke Berglund, Rolf Larsson, Peter Nygren,
Tópico(s)CAR-T cell therapy research
Referência(s)